Adaption and Validation of PROMIS for use in Vasculitis
PROMIS 用于血管炎的调整和验证
基本信息
- 批准号:8461762
- 负责人:
- 金额:$ 41.66万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-09-15 至 2016-08-31
- 项目状态:已结题
- 来源:
- 关键词:Antineutrophil Cytoplasmic AntibodiesBoxingChurg-Strauss SyndromeClinical ResearchClinical TrialsComputersCross-Sectional StudiesDataDevelopmentDiseaseEffectivenessFatigueGoalsHealthIndividualInflammationInformation SystemsInstitutesIschemiaLeadLongitudinal StudiesMeasurementMeasuresMethodsMicroscopic polyangiitisMissionNorth AmericaOrganOutcomeOutcome MeasurePatient Outcomes AssessmentsPatientsPhysiciansPopulationProcessQuestionnairesRandomizedRare DiseasesRegistriesRelative (related person)ReportingRequest for ApplicationsResearchResearch InfrastructureResearch PersonnelResearch Project GrantsResourcesSF-36Sample SizeSymptomsSystemTestingTherapeutic AgentsTherapeutic Clinical TrialTimeUnited States National Institutes of HealthValidationVasculitisWorkbaseburden of illnesscohortcomparative effectivenesseffectiveness trialhealth related quality of lifehighly advanced systemimpressionimprovedinstrumentnovelprimary outcomeresearch clinical testingstandard measuretool
项目摘要
DESCRIPTION (provided by applicant): The overarching goal of the proposed work is to more effectively incorporate patients' perspectives into the assessment of disease activity and burden among patients with ANCA-associated vasculitis [AAV, granulomatosis with polyangiitis (Wegener's), microscopic polyangiitis, and Churg-Strauss syndrome]. This project seeks to demonstrate the validity and feasibility of incorporating the Patient Reported Outcomes Measurement System (PROMIS) into clinical research in AAV. This project has five specific aims: Specific Aim 1: Determine the construct validity of PROMIS instruments in AAV through cross-sectional analysis of subjects within the Vasculitis Clinical Research Consortium (VCRC) patient cohort, utilizing other HRQOL instruments and physician-determined measures of vasculitis disease activity and damage as constructs. Specific Aim 2: Determine the longitudinal validity, responsiveness, and clinically important difference for the PROMIS instruments in an AAV population by comparing changes over time to the clinical evaluation, fatigue SF-36, and a patient global impression of change measure. Specific Aim 3: Determine the additive/complementary value of PROMIS assessments in defining the disease beyond standard measures of HRQOL and disease activity in AAV. Specific Aim 4: Use selected PROMIS instruments in a randomized therapeutic clinical trial in AAV. Specific Aim 5: Establish a "tool box" of PROMIS symptomatic measures that are the most useful for clinical research in AAV by assessing i) patients' ratings of the importance of the instrument domains; ii) the usefulness in describing the extent of the disease process; and iii) the relative efficiency and feasibility of the use of various PROMIS instruments in an RCT; and then providing researchers with informed guidance to integrate PROMIS into clinical investigation of AAV. The study will be conducted by the Vasculitis Clinical Research Consortium (VCRC), the largest collaborative clinical research infrastructure in North America and is fully responsive to the NIH RFA for PROMIS by utilizing already-established research cohorts and resources, including i) the VCRC Longitudinal Study cohorts for AAV; ii) the RITAZAREM clinical trial in AAV; and iii) the on-line VCRC Patient Contact Registry.
PUBLIC HEALTH RELEVANCE: The proposed project will explore novel methods to incorporate how patients with vasculitis feel about the burden of their disease into clinical research in order to both better understand the disease and to help develop a set of research tools to measure the disease from the patients' perspective. The project will test the Patient Reported Outcomes Measurement System (PROMIS), a highly advanced system developed by the NIH to measure patients' ratings of disease-related health problems. The research will produce important advances to provide a method to incorporate patients' own assessments of their disease into research. This project is fully relevant to the mission and goals of the Nationa Institutes of Health.
描述(由申请人提供):拟议工作的总体目标是更有效地将患者的观点纳入ANCA相关血管炎患者的疾病活动性和负担的评估中[AAV、肉芽肿病伴多血管炎(Wegener‘s)、显微镜下的多血管炎和Churg-Strauss综合征]。本项目旨在证明将患者报告结果测量系统(PROIS)纳入AAV临床研究的有效性和可行性。该项目有五个具体目标:具体目标1:通过对脉管炎临床研究联盟(VCRC)患者队列中的受试者进行横断面分析,利用其他HRQOL工具和医生确定的脉管炎疾病活动和损害的测量作为结构,确定PROMIS工具在AAV中的结构有效性。具体目标2:通过比较随时间的变化与临床评估、疲劳SF-36和患者对变化的总体印象的测量,确定PROMIS工具在AAV人群中的纵向有效性、响应性和临床重要性差异。具体目标3:确定PROMIS评估在确定疾病时的相加/补充价值,超出AAV的HRQOL和疾病活动性的标准衡量标准。具体目标4:在AAV的随机治疗临床试验中使用精选的PROMIS器械。具体目标5:通过评估i)患者对仪器领域重要性的评级;ii)描述疾病过程的程度的有用性;iii)在随机对照试验中使用各种PROMIS仪器的相对效率和可行性;然后为研究人员提供知情指导,以将PROMIS纳入AAV的临床研究,从而建立一个对AAV临床研究最有用的PROMIS症状测量“工具箱”。这项研究将由北美最大的协作性临床研究基础设施脉管炎临床研究联盟(VCRC)进行,并通过利用已经建立的研究队列和资源,充分响应NIH PROMIS的RFA,包括i)AAV的VCRC纵向研究队列;ii)AAV的RITAZAREM临床试验;以及iii)在线VCRC患者联系登记。
与公共卫生相关:拟议的项目将探索新的方法,将脉管炎患者对疾病负担的感受纳入临床研究,以便更好地了解疾病,并帮助开发一套从患者角度衡量疾病的研究工具。该项目将测试患者报告结果测量系统(PROIS),这是美国国立卫生研究院开发的一个非常先进的系统,用于测量患者对与疾病相关的健康问题的评级。这项研究将产生重要的进展,提供一种方法,将患者自己对自己疾病的评估纳入研究。该项目与国家卫生研究院的使命和目标完全相关。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Peter A Merkel其他文献
Glucocorticoid Minimization in ANCA-Associated Vasculitis: An International Survey of Clinicians
ANCA 相关血管炎中糖皮质激素最小化:一项国际临床医生调查
- DOI:
- 发表时间:
2024 - 期刊:
- 影响因子:3.9
- 作者:
D. Massicotte;M. Canney;Priscilla Karnabi;Peter A Merkel;Rachel B. Jones;Ruth J. Pepper;Alan D. Salama;V. Derebail;N. Milman;Mats Junek;C. Pagnoux;David R W Jayne;Michael Walsh - 通讯作者:
Michael Walsh
Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis.
贝那利珠单抗与美泊利珠单抗治疗嗜酸性肉芽肿性多血管炎。
- DOI:
- 发表时间:
2024 - 期刊:
- 影响因子:158.5
- 作者:
Michael E. Wechsler;P. Nair;Benjamin Terrier;Bastian Walz;Arnaud Bourdin;D. Jayne;David J Jackson;F. Roufosse;L. Börjesson Sjö;Ying Fan;M. Jison;C. McCrae;S. Necander;A. Shavit;C. Walton;Peter A Merkel - 通讯作者:
Peter A Merkel
The impact of treatment with avacopan on health-related quality of life in antineutrophil cytoplasmic antibody-associated vasculitis: a post-hoc analysis of data from the ADVOCATE trial
阿瓦可班治疗对中性粒细胞胞浆抗体相关性血管炎患者健康相关生活质量的影响:对 ADVOCATE 试验数据的事后分析
- DOI:
10.1016/s2665-9913(23)00092-9 - 发表时间:
2023-08-01 - 期刊:
- 影响因子:16.400
- 作者:
Vibeke Strand;David R W Jayne;Audra Horomanski;Huibin Yue;Pirow Bekker;Peter A Merkel;Chen Au Peh;Aron Chakera;Bruce Cooper;Jagadeesh Kurtkoti;Daman Langguth;Vicki Levidiotis;Grant Luxton;Peter Mount;David Mudge;Euan Noble;Richard Phoon;Dwarakanathan Ranganathan;Angus Ritchie;Jessica Ryan;Mary Chester Wasko - 通讯作者:
Mary Chester Wasko
Peter A Merkel的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Peter A Merkel', 18)}}的其他基金
Adaption and Validation of PROMIS for use in Vasculitis
PROMIS 用于血管炎的调整和验证
- 批准号:
8545674 - 财政年份:2012
- 资助金额:
$ 41.66万 - 项目类别:
Adaption and Validation of PROMIS for use in Vasculitis
PROMIS 用于血管炎的调整和验证
- 批准号:
8708763 - 财政年份:2012
- 资助金额:
$ 41.66万 - 项目类别:
Adaption and Validation of PROMIS for use in Vasculitis
PROMIS 用于血管炎的调整和验证
- 批准号:
8917091 - 财政年份:2012
- 资助金额:
$ 41.66万 - 项目类别:
Plasma Exchange and Glucocorticoids for Treatment of ANCA-Associated Vasculitis
血浆置换和糖皮质激素治疗 ANCA 相关性血管炎
- 批准号:
8537733 - 财政年份:2009
- 资助金额:
$ 41.66万 - 项目类别:
相似海外基金
Boxing Day: Time and Contradiction in Transgender Poetry
节礼日:跨性别诗歌中的时间与矛盾
- 批准号:
2889741 - 财政年份:2023
- 资助金额:
$ 41.66万 - 项目类别:
Studentship
A Study on White-Boxing of Malicious Domain Name Detection System Using Machine Learning
基于机器学习的恶意域名检测系统白盒研究
- 批准号:
20K11800 - 财政年份:2020
- 资助金额:
$ 41.66万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Women in boxing: Negotiating identity, gender, health and wellbeing
拳击界的女性:协商身份、性别、健康和福祉
- 批准号:
2274933 - 财政年份:2019
- 资助金额:
$ 41.66万 - 项目类别:
Studentship
Boxing the mNAP (a mobile Noise Abatement Pod for raising awareness of the effects of noise pollution)
装箱 mNAP(一种移动降噪吊舱,用于提高人们对噪音污染影响的认识)
- 批准号:
AH/M005658/1 - 财政年份:2014
- 资助金额:
$ 41.66万 - 项目类别:
Research Grant
Boxing clever: artificial nest boxes as a conservation and research tool
拳击聪明:人造巢箱作为保护和研究工具
- 批准号:
LP110200782 - 财政年份:2012
- 资助金额:
$ 41.66万 - 项目类别:
Linkage Projects
Acute and Chronic Brain Injury in Professional Boxing
职业拳击中的急性和慢性脑损伤
- 批准号:
nhmrc : 466609 - 财政年份:2007
- 资助金额:
$ 41.66万 - 项目类别:
NHMRC Postgraduate Scholarships
The situational meanings of so-called masculine directives in a Japanese boxing gym
日本拳击馆中所谓男性指令的情境含义
- 批准号:
18520328 - 财政年份:2006
- 资助金额:
$ 41.66万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
FOLLOW-UP STUDY OF NEUROLOGICAL RISKS IN AMATEUR BOXING
业余拳击神经风险的后续研究
- 批准号:
3412295 - 财政年份:1988
- 资助金额:
$ 41.66万 - 项目类别:
FOLLOW-UP STUDY OF NEUROLOGICAL RISKS IN AMATEUR BOXING
业余拳击神经风险的后续研究
- 批准号:
3412299 - 财政年份:1988
- 资助金额:
$ 41.66万 - 项目类别:
FOLLOW-UP STUDY OF NEUROLOGICAL RISKS IN AMATEUR BOXING
业余拳击神经风险的后续研究
- 批准号:
3412300 - 财政年份:1988
- 资助金额:
$ 41.66万 - 项目类别: